• 4857 Citations
  • 38 h-Index
19962020
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 22 Similar Profiles
Pharmacokinetics Medicine & Life Sciences
docetaxel Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Topotecan Medicine & Life Sciences
Nanoparticles Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1997 2020

Research Output 1996 2018

A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer

McRee, A. J., Marcom, P. K., Moore, D. T., Zamboni, W. C., Kornblum, Z. A., Hu, Z., Phipps, R., Anders, C. K., Reeder-Hayes, K., Carey, L. A., Weck, K. E., Perou, C. M. & Dees, E. C., Aug 1 2018, In : Clinical Breast Cancer. 18, 4, p. 289-297 9 p.

Research output: Contribution to journalArticle

Phosphotransferases
Breast Neoplasms
Maximum Tolerated Dose
Pharmacokinetics
Aspartate Aminotransferases
1 Citations

Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer

Byrne, J. D., Jajja, M. R. N., O’Neill, A. T., Schorzman, A. N., Keeler, A. W., Luft, J. C., Zamboni, W. C., DeSimone, J. M. & Yeh, J. J., Jun 1 2018, In : Cancer Chemotherapy and Pharmacology. 81, 6, p. 991-998 8 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Pharmaceutical Preparations
irinotecan
oxaliplatin
Iontophoresis
1 Citations

MerTK as a therapeutic target in glioblastoma: Neuro Oncol

Wu, J., Frady, L. N., Bash, R. E., Cohen, S. M., Schorzman, A. N., Su, Y. T., Irvin, D. M., Zamboni, W. C., Wang, X., Frye, S. V., Ewend, M. G., Sulman, E. P., Gilbert, M. R., Earp, H. S. & Miller, C. R., Jun 13 2018, In : Neuro-Oncology. 20, 1, p. 92-102 11 p.

Research output: Contribution to journalArticle

Glioblastoma
Macrophages
Neoplasms
Therapeutics
UNC2025

Methods and study designs for characterizing the pharmacokinetics and pharmacodynamics of carrier-mediated agents

Schorzman, A. N., Lucas, A. T., Kagel, J. R. & Zamboni, W. C., Jan 1 2018, Methods in Molecular Biology. Humana Press Inc., p. 201-228 28 p. (Methods in Molecular Biology; vol. 1831)

Research output: Chapter in Book/Report/Conference proceedingChapter

Pharmacokinetics
Pharmaceutical Preparations
Nanoparticles
Immunomagnetic Separation
Microdialysis

Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer

Sanoff, H. K. , Goldberg, R. M. , Ivanova, A. , O'Reilly, S. , Kasbari, S. S. , Kim, R. D. , McDermott, R. , Moore, D. T. , Zamboni, W. , Grogan, W. , Cohn, A. L. , Bekaii-Saab, T. S. , Leonard, G. , Ryan, T. , Olowokure, O. O. , Fernando, N. H. , McCaffrey, J. , El-Rayes, B. F. , Horgan, A. M. , Sherrill, G. B. & 2 others Yacoub, G. H. & O'Neil, B. H., Aug 1 2018, In : Cancer. 124, 15, p. 3118-3126 9 p.

Research output: Contribution to journalArticle

irinotecan
Leucovorin
Fluorouracil
Colorectal Neoplasms
Placebos